GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (FRA:EZB) » Definitions » Shiller PE Ratio

Enzo Biochem (FRA:EZB) Shiller PE Ratio : (As of Jun. 18, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzo Biochem Shiller PE Ratio Historical Data

The historical data trend for Enzo Biochem's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Shiller PE Ratio Chart

Enzo Biochem Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 204.37

Enzo Biochem Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 204.37 381.72 134.25 -

Competitive Comparison of Enzo Biochem's Shiller PE Ratio

For the Diagnostics & Research subindustry, Enzo Biochem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Shiller PE Ratio falls into.



Enzo Biochem Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Enzo Biochem's E10 for the quarter that ended in Apr. 2024 is calculated as:

For example, Enzo Biochem's adjusted earnings per share data for the three months ended in Apr. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Apr. 2024 (Change)*Current CPI (Apr. 2024)
=-0.056/131.7762*131.7762
=-0.056

Current CPI (Apr. 2024) = 131.7762.

Enzo Biochem Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201407 -0.052 100.520 -0.068
201410 -0.063 100.176 -0.083
201501 -0.077 98.604 -0.103
201504 -0.055 99.824 -0.073
201507 0.173 100.691 0.226
201510 0.089 100.346 0.117
201601 0.138 99.957 0.182
201604 -0.044 100.947 -0.057
201607 0.697 101.524 0.905
201610 -0.027 101.988 -0.035
201701 -0.019 102.456 -0.024
201704 -0.001 103.167 -0.001
201707 0.002 103.278 0.003
201710 -0.009 104.070 -0.011
201801 -0.016 104.578 -0.020
201804 -0.049 105.708 -0.061
201807 -0.103 106.324 -0.128
201810 -0.113 106.695 -0.140
201901 -0.158 106.200 -0.196
201904 0.418 107.818 0.511
201907 -0.098 108.250 -0.119
201910 -0.145 108.577 -0.176
202001 -0.144 108.841 -0.174
202004 -0.193 108.173 -0.235
202007 -0.061 109.318 -0.074
202010 0.009 109.861 0.011
202101 0.041 110.364 0.049
202104 0.033 112.673 0.039
202107 0.051 115.183 0.058
202110 -0.043 116.696 -0.049
202201 -0.044 118.619 -0.049
202204 -0.093 121.978 -0.100
202207 -0.177 125.002 -0.187
202210 -0.223 125.734 -0.234
202301 -0.213 126.223 -0.222
202304 -0.283 127.992 -0.291
202307 1.058 128.974 1.081
202310 -0.123 129.810 -0.125
202401 -0.055 130.124 -0.056
202404 -0.056 131.776 -0.056

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzo Biochem  (FRA:EZB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Enzo Biochem Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem (FRA:EZB) Business Description

Traded in Other Exchanges
Address
527 Madison Avenue, New York, NY, USA, 10022
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Enzo Biochem (FRA:EZB) Headlines

No Headlines